Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis

BACKGROUND: A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for women and men aged 30 to 45 years in the context of cervical cancer screening practice was evaluated to inform...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS Med
Hoofdauteurs: Kim, Jane J., Simms, Kate T., Killen, James, Smith, Megan A., Burger, Emily A., Sy, Stephen, Regan, Catherine, Canfell, Karen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2021
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951902/
https://ncbi.nlm.nih.gov/pubmed/33705382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1003534
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items